PQ 711
711. Deputy Mairéad Farrell asked the Minister for Health the reason the HSE claims to be saving €4 million per year using biosimilar teriparatide, when the cost of managing fractures is estimated to be increasing by approximately €100 million per year. [36460/24]
Introduced
18 September 2024
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
18 September 2024
Summary
711. Deputy Mairéad Farrell asked the Minister for Health the reason the HSE claims to be saving €4 million per year using biosimilar teriparatide, when the cost of managing fractures is estimated to be increasing by approximately €100 million per year. [36460/24]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Service Executive
Health Service Executive
xml · EN · 18 September 2024
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2024-09-18/711/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2024-09-18/pq_711